These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 20127710

  • 1. RECK-mediated inhibition of glioma migration and invasion.
    Silveira Corrêa TC, Massaro RR, Brohem CA, Taboga SR, Lamers ML, Santos MF, Maria-Engler SS.
    J Cell Biochem; 2010 May; 110(1):52-61. PubMed ID: 20127710
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Altered actin cytoskeleton and inhibition of matrix metalloproteinase expression by vanadate and phenylarsine oxide, inhibitors of phosphotyrosine phosphatases: modulation of migration and invasion of human malignant glioma cells.
    Chintala SK, Kyritsis AP, Mohan PM, Mohanam S, Sawaya R, Gokslan Z, Yung WK, Steck P, Uhm JH, Aggarwal BB, Rao JS.
    Mol Carcinog; 1999 Dec; 26(4):274-85. PubMed ID: 10569804
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
    Deryugina EI, Soroceanu L, Strongin AY.
    Cancer Res; 2002 Jan 15; 62(2):580-8. PubMed ID: 11809713
    [Abstract] [Full Text] [Related]

  • 6. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion.
    Liu LT, Chang HC, Chiang LC, Hung WC.
    Cancer Res; 2003 Jun 15; 63(12):3069-72. PubMed ID: 12810630
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of membrane-type 1 matrix metalloproteinase at cell-matrix adhesions.
    Takino T, Saeki H, Miyamori H, Kudo T, Sato H.
    Cancer Res; 2007 Dec 15; 67(24):11621-9. PubMed ID: 18089791
    [Abstract] [Full Text] [Related]

  • 8. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.
    Masui T, Doi R, Koshiba T, Fujimoto K, Tsuji S, Nakajima S, Koizumi M, Toyoda E, Tulachan S, Ito D, Kami K, Mori T, Wada M, Noda M, Imamura M.
    Clin Cancer Res; 2003 May 15; 9(5):1779-84. PubMed ID: 12738734
    [Abstract] [Full Text] [Related]

  • 9. Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion.
    Liu L, Wu J, Ying Z, Chen B, Han A, Liang Y, Song L, Yuan J, Li J, Li M.
    Cancer Res; 2010 May 01; 70(9):3750-9. PubMed ID: 20388776
    [Abstract] [Full Text] [Related]

  • 10. Testican 2 abrogates inhibition of membrane-type matrix metalloproteinases by other testican family proteins.
    Nakada M, Miyamori H, Yamashita J, Sato H.
    Cancer Res; 2003 Jun 15; 63(12):3364-9. PubMed ID: 12810672
    [Abstract] [Full Text] [Related]

  • 11. Semaphorin 5A and plexin-B3 regulate human glioma cell motility and morphology through Rac1 and the actin cytoskeleton.
    Li X, Law JW, Lee AY.
    Oncogene; 2012 Feb 02; 31(5):595-610. PubMed ID: 21706053
    [Abstract] [Full Text] [Related]

  • 12. RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness.
    Kang HG, Kim HS, Kim KJ, Oh JH, Lee MR, Seol SM, Han I.
    J Orthop Res; 2007 May 02; 25(5):696-702. PubMed ID: 17262820
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
    Takeuchi T, Hisanaga M, Nagao M, Ikeda N, Fujii H, Koyama F, Mukogawa T, Matsumoto H, Kondo S, Takahashi C, Noda M, Nakajima Y.
    Clin Cancer Res; 2004 Aug 15; 10(16):5572-9. PubMed ID: 15328199
    [Abstract] [Full Text] [Related]

  • 15. The benzoylurea derivative F13 inhibits cell growth, migration and invasion through inducing expression of ERK1/2-mediated RECK in fibrosarcoma HT-1080 cells.
    Jin H, Ren K, He HW, Liu X, Song DQ, Shao RG.
    Anticancer Drugs; 2010 Apr 15; 21(4):372-80. PubMed ID: 20051826
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer.
    Song SY, Son HJ, Nam E, Rhee JC, Park C.
    Eur J Cancer; 2006 Jan 15; 42(1):101-8. PubMed ID: 16324834
    [Abstract] [Full Text] [Related]

  • 19. Glycitein inhibits glioma cell invasion through down-regulation of MMP-3 and MMP-9 gene expression.
    Lee EJ, Kim SY, Hyun JW, Min SW, Kim DH, Kim HS.
    Chem Biol Interact; 2010 Apr 15; 185(1):18-24. PubMed ID: 20188714
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.